May 29, 2017 | Hong Kong-based investment group AID Partners has acquired Israeli diagnostics startup GeneSort for $23 million. Founded in 2013, GeneSort is led by Dr. Gil Pogozelich. The molecular diagnostics company is focused on integrating genomics with personalized therapeutic approaches.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli Startup Rings Closing Bell At Nasdaq in NYC
March 28, 2024
Israeli, US Companies Unite To Make More Milk From Mushrooms
March 27, 2024
Facebook comments